What's in Fox Chase Cancer Center's pipeline?

Fox Chase Cancer Center has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Fox Chase Cancer Center's portfolio?

Top competitors by shared drug class: Carolinas Pain Institute, Friends Research Institute, Inc., Indivior Inc., King's College London, Merck Sharp & Dohme LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/fox-chase-cancer-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Fox Chase Cancer Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fox Chase Cancer Center pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Use of buprenorphine with FAO > 30 OME	Use of buprenorphine with FAO > 30 OME	marketed	Partial mu-opioid receptor agonist	Mu-opioid receptor (μ-OR)	Pain Management / Opioid Use Disorder
targeted therapy	targeted therapy	marketed			Oncology

Therapeutic area mix

Oncology · 1
Pain Management / Opioid Use Disorder · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Carolinas Pain Institute · 1 shared drug class
Friends Research Institute, Inc. · 1 shared drug class
Indivior Inc. · 1 shared drug class
King's College London · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
Mundipharma (China) Pharmaceutical Co. Ltd · 1 shared drug class
NYU Langone Health · 1 shared drug class
BioDelivery Sciences International · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fox Chase Cancer Center:

Cite this brief

Drug Landscape (2026). Fox Chase Cancer Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fox-chase-cancer-center. Accessed 2026-05-17.